Impact of first-line dalbavancin for cellulitis on hospital admissions and costs: A case series
Background: Many patients with cellulitis are treated with oral antibiotics as outpatients, but some require hospital admission for intravenous antibiotics. During the coronavirus disease 2019 pandemic, Betsi Cadwaladr University Health Board in Wales approved use of dalbavancin as first-line intrav...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-09-01
|
| Edice: | Journal of Global Antimicrobial Resistance |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2213716524001085 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|